Senior Director, Preclinical Program Lead

BlueRock Therapeutics is at the forefront of cellular therapy, dedicated to developing groundbreaking medicines that significantly improve patients' lives suffering from neurological and ophthalmological disease. We are seeking a highly collaborative and dynamic individual to join our New York City site (in person) as a Preclinical Program Lead, Retinal Cell Therapies and Translational Neuroscience. The role has two primary focus areas in acting as Program Lead for the OpCT-002/003 preclinical program and Translational Neuroscience Coordinator for BlueRock’s preclinical assets. Reporting directly to the CSO, this role will be instrumental in advancing our cell+gene pipeline. This role requires significant industry experience and specific, deep knowledge of retinal cell biology, along with demonstrated clinical development experience.

This is an ideal opportunity for a clinical developer who is passionate about research, or vice versa, eager to bridge the gap between early discovery and patient impact.

This is an exceptional opportunity for a talented scientist to make a tangible impact on a new class of medicines and gain invaluable career experience within the cell therapy field. You'll join a highly motivated, world-class team of scientists and engineers in an exciting and engaging work environment.